149 related articles for article (PubMed ID: 9830438)
1. A 2-week pretreatment with 13-cis-retinoic acid + interferon-alpha-2a prior to definitive radiation improves tumor tissue oxygenation in cervical cancers.
Dunst J; Hänsgen G; Krause U; Füchsel G; Köhler U; Becker A
Strahlenther Onkol; 1998 Nov; 174(11):571-4. PubMed ID: 9830438
[TBL] [Abstract][Full Text] [Related]
2. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon.
Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263
[TBL] [Abstract][Full Text] [Related]
3. 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.
Lippman SM; Kavanagh JJ; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong WK; Holdener E; Krakoff IH
J Natl Cancer Inst; 1992 Feb; 84(4):241-5. PubMed ID: 1734085
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893).
Skeel RT; Huang J; Manola J; Wilding G; Dreicer R; Walker P; Muggia F; Crawford ED; Dutcher JP; Loehrer PJ
Cancer Invest; 2003; 21(1):41-6. PubMed ID: 12643008
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix.
Knocke TH; Weitmann HD; Feldmann HJ; Selzer E; Pötter R
Radiother Oncol; 1999 Nov; 53(2):99-104. PubMed ID: 10665785
[TBL] [Abstract][Full Text] [Related]
6. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.
Lippman SM; Parkinson DR; Itri LM; Weber RS; Schantz SP; Ota DM; Schusterman MA; Krakoff IH; Gutterman JU; Hong WK
J Natl Cancer Inst; 1992 Feb; 84(4):235-41. PubMed ID: 1734084
[TBL] [Abstract][Full Text] [Related]
7. In vitro radiosensitization of human cervical carcinoma cells by combined use of 13-cis-retinoic acid and interferon-alpha2a.
Ryu S; Kim OB; Kim SH; He SQ; Kim JH
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):869-73. PubMed ID: 9652851
[TBL] [Abstract][Full Text] [Related]
8. Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma.
Enzinger PC; Ilson DH; Saltz LB; Martin LK; Kelsen DP
Cancer; 1999 Mar; 85(6):1213-7. PubMed ID: 10189124
[TBL] [Abstract][Full Text] [Related]
9. Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: antitumor activity in a phase II trial and interactions in vitro.
Motzer RJ; Schwartz L; Law TM; Murphy BA; Hoffman AD; Albino AP; Vlamis V; Nanus DM
J Clin Oncol; 1995 Aug; 13(8):1950-7. PubMed ID: 7636535
[TBL] [Abstract][Full Text] [Related]
10. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK
J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495
[TBL] [Abstract][Full Text] [Related]
11. [Feasibility study: concurrent 13-cis-retinoic acid, alfa-2a interferon and radiotherapy in the treatment of 23 patients with advanced cervix uteri epidermoid carcinoma].
Paredes Espinoza M; Delgadillo Madrueño F; Paredes Casillas P; Delgadillo Hernández JJ; Ayala Castellanos MM; Alvarez Márquez V; Buenrostro Ahued MA; Arias Castro G
Ginecol Obstet Mex; 1995 May; 63():205-9. PubMed ID: 7789851
[TBL] [Abstract][Full Text] [Related]
12. Tumor hypoxia, p53, and prognosis in cervical cancers.
Haensgen G; Krause U; Becker A; Stadler P; Lautenschlaeger C; Wohlrab W; Rath FW; Molls M; Dunst J
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):865-72. PubMed ID: 11429213
[TBL] [Abstract][Full Text] [Related]
13. Oxygen tension in transplanted mouse osteosarcomas during fractionated high-LET- and low-LET radiotherapy--predictive aspects for choosing beam quality?
Auberger T; Thürriegl B; Freude T; Weissfloch L; Senekowitsch-Schmidke R; Kneschaurek P; Wagner FM; Molls M
Strahlenther Onkol; 1999 Jun; 175 Suppl 2():52-6. PubMed ID: 10394398
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix.
Hallum AV; Alberts DS; Lippman SM; Inclan L; Shamdas GJ; Childers JM; Surwit EA; Modiano M; Hatch KD
Gynecol Oncol; 1995 Mar; 56(3):382-6. PubMed ID: 7705672
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis.
Rofstad EK; Sundfør K; Lyng H; Tropé CG
Br J Cancer; 2000 Aug; 83(3):354-9. PubMed ID: 10917551
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of 32 cervico-uterine cancer patients with 13-cis-retinoic acid and interferon alpha].
Paredes Espinoza M; Lippman SM; Kavanagh JJ; Delgadillo Madrueño F; Paredes Casillas P; Bañuelos Acosta O; Alvarez Márquez V; Buenrostro Ahued MA; de Alba Ayala I; Arias Castro G
Rev Invest Clin; 1994; 46(2):105-11. PubMed ID: 8052740
[TBL] [Abstract][Full Text] [Related]
17. Oxygenation status of cervical carcinomas before and during spinal anesthesia for application of brachytherapy.
Weitmann HD; Gustorff B; Vaupel P; Knocke TH; Pötter R
Strahlenther Onkol; 2003 Sep; 179(9):633-40. PubMed ID: 14628130
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma.
Dillman RO; Shea WM; Tai DF; Mahdavi K; Barth NM; Kharkar BR; Poor MM; Church CK; DePriest C
Neuro Oncol; 2001 Jan; 3(1):35-41. PubMed ID: 11305415
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: a pilot study.
Park TK; Lee JP; Kim SN; Choi SM; Kudelka AP; Kavanagh JJ
Eur J Gynaecol Oncol; 1998; 19(1):35-8. PubMed ID: 9476056
[TBL] [Abstract][Full Text] [Related]
20. [13-cis retinoic acid and interferon-alfa-2a as palliative therapy in pretreated, recurrent squamous epithelial carcinoma of the cervix uteri and vulva].
Römisch M; Meier W; Kimmig R; Hepp H
Geburtshilfe Frauenheilkd; 1996 Oct; 56(10):520-4. PubMed ID: 9036064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
